Lot certificates published
Plain, secure packaging
Catalog/Retatrutide
Retatrutide
#1039
Lyophilized Peptide

Retatrutide 40mg

Retatrutide (LY3437943) is a peptide agonist of the GIP, GLP-1 and glucagon receptors. Structural and receptor-mutagenesis research examines how the same peptide engages all three receptors. This listing contains 40mg of lyophilized material. Supplied strictly for in-vitro research and laboratory use only. Not for human or animal use.

Select Option

Single (40mg)$169.99

2+ save 5% · 5+ save 10% · 10+ save 20%

Quantity

1
= $169.99
Buy now

Mechanism of Action

Retatrutide is a triple agonist at GLP-1R, GIPR and the glucagon receptor (GCGR). Li et al. (2024) determined cryo-EM structures of retatrutide bound to each receptor in complex with Gs and examined receptor mutations using cAMP signaling assays. The study identifies shared and receptor-specific peptide contacts in these experimental systems.

Properties

CAS Number

2381089-83-2

Half-Life

Not established

Storage

Store lyophilized at -20°C. Reconstituted at 2-8°C, use within 30 days.

Shipping & Delivery

  • Same-day dispatch on orders placed before 2 PM MST (Arizona — no daylight saving).
  • US shipping from $5. Free Priority on orders $100+ (before discounts).
  • Plain, unmarked packaging — no branding or product names on the outside.
  • Ships to all 50 states, DC, Puerto Rico & the U.S. Virgin Islands; tracking emailed on every order.
Full shipping details

Quality & Testing

  • No third-party certificate has been published for this compound yet.
  • USA-based; dispatched from Phoenix, Arizona.
  • Supplied strictly for in-vitro laboratory research — not for human use.

Certificates are published for each lot we have tested — see the 14 published so far.

Research Applications

1Triple-receptor complex structural analysis
2Receptor-mutagenesis and cAMP signaling assays
3Comparative incretin and glucagon receptor pharmacology

References & Citations

(1)
1

Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide

Li W, Zhou Q, Cong Z, et al.

Cell Discov (2024)PMID: 39019866 DOI

Research Use Only

This product is intended strictly for in-vitro research, educational, and laboratory use. Not for human consumption. The information provided is based on published research and does not constitute medical advice.

Research reference

A published identity, mechanism, and bibliography record corresponds to this catalog entry.

Research reference: Retatrutide

More references from the Research Library (9)

Further papers cited in the Library's Retatrutide record, each checked against PubMed. They describe the compound in research settings and are not statements about this product. See the full record for its identity, structure and complete bibliography.

  1. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept.

    Coskun T, Urva S, Roell WC, et al.

    Cell metabolism (2022)In vitro · Animal · Human participants (interventional)PMID 35985340
  2. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.

    Jastreboff AM, Kaplan LM, Frías JP, et al.

    The New England journal of medicine (2023)Human participants (interventional)PMID 37366315
  3. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA.

    Rosenstock J, Frias J, Jastreboff AM, et al.

    Lancet (London, England) (2023)Human participants (interventional)PMID 37385280
  4. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.

    Sanyal AJ, Kaplan LM, Frias JP, et al.

    Nature medicine (2024)Human participants (interventional)PMID 38858523
  5. Pharmacology, physiology, and mechanisms of incretin hormone action.

    Campbell JE, Drucker DJ

    Cell metabolism (2013)Review articlePMID 23684623
  6. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein.

    Zhang Y, Sun B, Feng D, et al.

    Nature (2017)In vitroPMID 28538729
  7. Structural basis for ligand recognition of incretin receptors.

    Underwood CR, Parthier C, Reedtz-Runge S

    Vitamins and hormones (2010)Review articlePMID 21094903
  8. Structure of the full-length glucagon class B G-protein-coupled receptor.

    Zhang H, Qiao A, Yang D, et al.

    Nature (2017)In vitroPMID 28514451
  9. Structure of the glucagon receptor in complex with a glucagon analogue.

    Zhang H, Qiao A, Yang L, et al.

    Nature (2018)In vitroPMID 29300013